Concepedia

Yue Huang

YH

Statistics

Publications

58

Citations

2.1K

H-Index

26

Active since

2002

Affiliations

AstraZeneca (United States)(Current)

Chinese Academy of Sciences

Shanxi University

Sun Yat-sen University

AstraZeneca (United Kingdom)

Yue Huang is an author at AstraZeneca (United States) specializing in pharmacy, life sciences, and pharmacology.

ORCID

Publications per year

2002–2025

58

Publications

58

The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in nonhuman primates and has an extended half-life in humans

Yueh–Ming Loo, Patrick M. McTamney, Rosalinda H. Arends et al. · Science Translational Medicine · 2022 · 215 citations · Full text

, , +17

Hypoxia‐induced tRNA‐derived fragments, novel regulatory factor for doxorubicin resistance in triple‐negative breast cancer

Yangyang Cui, Yue Huang, Xiaowei Wu et al. · Journal of Cellular Physiology · 2018 · 117 citations

, , +17

Mitochondria-Targeting Multifunctional Fluorescent Probe toward Polarity, Viscosity, and ONOO<sup>–</sup> and Cell Imaging

Yue Huang, Minglu Li, Qi Zan et al. · Analytical Chemistry · 2023 · 107 citations

, , +17

Evaluation of the CMIP6 Precipitation Simulations Over Global Land

Zhengyang Li, Tie Liu, Yue Huang et al. · Earth s Future · 2022 · 103 citations · Full text

, , +16

Serum tRNA‐derived fragments (tRFs) as potential candidates for diagnosis of nontriple negative breast cancer

Yue Huang, Han Ge, Mingjie Zheng et al. · Journal of Cellular Physiology · 2019 · 73 citations

, , +16

1–5 of 58